{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:36:47Z","timestamp":1784979407220,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Hand and Upper Limb Centre"},{"name":"Lawson Health Research Institute Internal Research Fund"},{"name":"University of Western Ontario Academic Development Fund"},{"DOI":"10.13039\/100002280","name":"Plastic Surgery Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002280","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbadis.2013.04.018","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T01:34:46Z","timestamp":1366767286000},"page":"1511-1519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease"],"prefix":"10.1016","volume":"1832","author":[{"given":"Christina","family":"Raykha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing Siang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon A.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.04.018_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00006534-200007000-00013","article-title":"Racial distribution of Dupuytren's disease in Department of Veterans Affairs patients","volume":"106","author":"Saboeiro","year":"2000","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00006534-200007000-00024","article-title":"Dupuytren's disease: an overview","volume":"106","author":"Saar","year":"2000","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0895-4356(99)00145-6","article-title":"Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik study","volume":"53","author":"Gudmundsson","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhsa.2005.09.018","article-title":"The heritability of Dupuytren's disease: familial aggregation and its clinical significance","volume":"31","author":"Hindocha","year":"2006","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0025","first-page":"222","article-title":"Permanent retraction of the fingers, produced by an affection of the palmar fascia","volume":"2","author":"Dupuytren","year":"1834","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-0712(21)00435-2","article-title":"The early history of Dupuytren's disease","volume":"15","author":"Elliot","year":"1999","journal-title":"Hand Clin."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0035","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jhsa.2006.09.006","article-title":"Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence","volume":"31","author":"Hindocha","year":"2006","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0749-0712(21)00444-3","article-title":"Surgical treatment of Dupuytren's disease","volume":"15","author":"Jabaley","year":"1999","journal-title":"Hand Clin."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0749-0712(21)00449-2","article-title":"Postsurgical rehabilitation of Dupuytren's disease","volume":"15","author":"Mullins","year":"1999","journal-title":"Hand Clin."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/030097401750065292","article-title":"Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease","volume":"30","author":"Gudmundsson","year":"2001","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/jhsb.2000.0382","article-title":"Cancer incidence in patients treated surgically for Dupuytren's contracture","volume":"25","author":"Wilbrand","year":"2000","journal-title":"J. Hand Surg. (Br.)"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1054\/jhsb.2001.0652","article-title":"Dupuytren's contracture and sarcoma","volume":"27","author":"Wilbrand","year":"2002","journal-title":"J. Hand Surg. (Br.)"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cancergencyto.2008.01.018","article-title":"No gene copy number changes in Dupuytren's contracture by array comparative genomic hybridization","volume":"183","author":"Kaur","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0300","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren's disease","author":"Dolmans","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-8794-5-15","article-title":"Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's contracture","volume":"5","author":"Satish","year":"2012","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-8794-1-10","article-title":"Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's contracture","volume":"1","author":"Satish","year":"2008","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture","volume":"64","author":"Qian","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhsa.2005.09.007","article-title":"Expression of a novel gene, MafB, in Dupuytren's disease","volume":"31","author":"Lee","year":"2006","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhsa.2007.11.010","article-title":"Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome","volume":"33","author":"Rehman","year":"2008","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhsa.2008.09.017","article-title":"Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes","volume":"34","author":"Shih","year":"2009","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2009.07.015","article-title":"Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells","author":"Vi","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0110","doi-asserted-by":"crossref","first-page":"E967","DOI":"10.1152\/ajpendo.2000.278.6.E967","article-title":"Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities","volume":"278","author":"Baxter","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ghir.2005.04.001","article-title":"IGFBP-6 five years on; not so \u2018forgotten\u2019?","volume":"15","author":"Bach","year":"2005","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2007-978723","article-title":"Insulin-like growth factor binding protein-6: the \u201cforgotten\u201d binding protein?","volume":"31","author":"Bach","year":"1999","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2474-4-16","article-title":"Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro","volume":"4","author":"Howard","year":"2003","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0130","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1073\/pnas.76.3.1274","article-title":"Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro","volume":"76","author":"Bell","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0363-5023(05)80105-4","article-title":"Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts","volume":"20","author":"Tomasek","year":"1995","journal-title":"J. Hand Surg. [Am]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0140","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1524-475X.2008.00392.x","article-title":"A review of fibroblast-populated collagen lattices","volume":"16","author":"Dallon","year":"2008","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0145","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/en.2010-0784","article-title":"Plasma distribution and signaling activities of IGF-II precursors","volume":"152","author":"Marks","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(00)00444-5","article-title":"Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells","volume":"174","author":"Leng","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0155","doi-asserted-by":"crossref","first-page":"22298","DOI":"10.1074\/jbc.M703066200","article-title":"Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6","volume":"282","author":"Fu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jbmt.2008.03.005","article-title":"Fibroblast mechanics in three-dimensional collagen matrices","volume":"12","author":"Grinnell","year":"2008","journal-title":"J. Bodyw. Mov. Ther."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0165","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1096\/fj.07-097014","article-title":"Distinguishing fibroblast promigratory and procontractile growth factor environments in 3-D collagen matrices","volume":"22","author":"Jiang","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0170","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.addr.2007.08.006","article-title":"Fibroblast mechanics in 3D collagen matrices","volume":"59","author":"Rhee","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0040-8166(88)90006-7","article-title":"The modulation of contraction of fibroblast populated collagen lattices by types I, II, and III collagen","volume":"20","author":"Ehrlich","year":"1988","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2474-5-41","article-title":"Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2","volume":"5","author":"Tse","year":"2004","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/excr.2000.4869","article-title":"Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast","volume":"257","author":"Vaughan","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.03-0699com","article-title":"Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation","volume":"18","author":"Grotendorst","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","article-title":"The role of transforming growth factor beta in Dupuytren's disease","volume":"21","author":"Badalamente","year":"1996","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0200","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0363-5023(94)90059-0","article-title":"Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia","volume":"19","author":"Alioto","year":"1994","journal-title":"J. Hand. Surg. [Am.]"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","article-title":"The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1","volume":"28","author":"Bisson","year":"2003","journal-title":"J. Hand Surg. (Br.)"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jbmt.2008.04.031","article-title":"Myofibroblasts work best under stress","volume":"13","author":"Wipff","year":"2009","journal-title":"J. Bodyw. Mov. Ther."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11926-009-0017-1","article-title":"Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis","volume":"11","author":"Hinz","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0220","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0225","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jcb.1196","article-title":"Regulation of the Akt\/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A","volume":"82","author":"Scalia","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0230","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-213X-7-124","article-title":"Dermal fibroblasts derived from fetal and postnatal humans exhibit distinct responses to insulin like growth factors","volume":"7","author":"Rolfe","year":"2007","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0235","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.biocel.2007.04.009","article-title":"Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways","volume":"39","author":"Yoo","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0240","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0245","doi-asserted-by":"crossref","first-page":"38239","DOI":"10.1074\/jbc.M206402200","article-title":"Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors","volume":"277","author":"Longo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ghir.2009.12.002","article-title":"Differential insulin-like growth factor II (IGF-II) expression: a potential role for breast cancer survival disparity","volume":"20","author":"Kalla Singh","year":"2012","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.1519","article-title":"Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo","volume":"94","author":"Gallicchio","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0260","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0959-8049(02)00240-X","article-title":"Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development","volume":"38","author":"Seurin","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0265","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1440-1746.2002.02703.x","article-title":"Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation","volume":"17","author":"Kim","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/path.2735","article-title":"IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression","volume":"222","author":"Kuo","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0275","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cellsig.2010.02.006","article-title":"Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate","volume":"22","author":"Iosef","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0280","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.bjc.6605767","article-title":"The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study","volume":"103","author":"Molife","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2013.04.018_bb0285","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/14712591003689980","article-title":"Figitumumab (CP-751,871) for cancer therapy","volume":"10","author":"Gualberto","year":"2010","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bbadis.2013.04.018_bb0290","first-page":"361","article-title":"Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer","volume":"12","author":"Scartozzi","year":"2011","journal-title":"Curr. Opin. Mol. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T18:22:57Z","timestamp":1644862977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0925443913001427"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.018","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}